International experts on epigenetics will meet at the upcoming Barcelona BioMed Conference organised by IRB Barcelona and the BBVA Foundation.
Researchers have transferred the patent to the biotech enterprise Genmedica Therapeutics.
What would motivate anyone to wake up early on a lazy springtime weekend morning, get dressed, and head to town? Research, of course! Fifty would-be scientists made their way to the Caixa Catalunya Cultural Centre in the "Pedrera" building in Barcelona on Saturday, March 3 for a day filled with science and fun. The occasion was Fes Recerca!, a series of hands-on science workshops aimed at the general public. The events, organized by the Parc Cientific de Barcelona over four weekends in February and March, provide an opportunity for amateur science buffs to experience what it is like to do research and learn about science projects...
Their work appears online this week in Proceedings of the National Academy of Sciences USA.
The study appears this week in the scientific journal Developmental Cell.
The research project “Improvement of the translational prediction of non-clinical assays in humans" (MELIUS), coordinated by Neuropharma S.A., part of the Zeltia group, and which involves the IRB Barcelona research group “Metabolic engineering and diabetes”, headed by Joan J. Guinovart, is one of 15 projects awarded funding through the CENIT programme by the Ministry of Industry, Commerce and Tourism.
MELIUS is the only project in biomedicine that will receive R+D+i funding through the CENIT programme. This project seeks to develop new tools to improve the prediction of...
Biocomputation, with supercomputers as key tools, is allowing scientists to respond to many unanswered questions about these crucial agents for life.
The study appears in this week’s online version of the prestigious scientific journal Proceedings of the National Academy of Sciences.
The topic of this conference won the Nobel Prize in Medicine and Physiology this year.
Just a few decades ago, ribonucleic acid (RNA) molecules were considered simple intermediaries between DNA, the protagonist of genetics, and proteins, the products of genes. RNA is now proving to play an important role in gene transcription and regulation, processes which are key to understanding how an organism develops and functions.
The study of ribonucleic acid molecules has provided many surprises, the most revolutionary being the mechanism of gene silencing, or RNA interference (RNAi). This discovery has had far-reaching repercussions in laboratories across the world, not only because the novelty of the mechanism, but also because it has enormous potential for clinical...